NDC 65219-119

NDC codes

FDA NDC Directory

Product NDC (as listed)65219-119Labeler and product segments. Claims need a package NDC.

Product NDC at billing width65219-0119Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
65219-119-10	65219011910	10 BAG in 1 CASE (65219-119-10) / 1000 mL in 1 BAG (65219-119-01)Marketed from Aug 31, 2022

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Potassium Chloride in Dextrose and Sodium Chloride
Generic name (nonproprietary): dextrose monohydrate, sodium chloride, and potassium chloride
Active ingredients: Dextrose monohydrate — 50 g/1000mLSodium chloride — 9 g/1000mLPotassium chloride — 2.98 g/1000mL
Dosage form: Injection, Solution
Route: Intravenous
Labeler: Fresenius Kabi USA, LLC
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 213445
Marketing start: Aug 31, 2022
Listing expires: Dec 31, 2026
Other FDA classes: Increased Large Intestinal Motility (Physiologic effect)Increased Large Intestinal Motility (Physiologic effect)Inhibition Large Intestine Fluid/Electrolyte Absorption (Physiologic effect)Inhibition Large Intestine Fluid/Electrolyte Absorption (Physiologic effect)Osmotic Activity (Mechanism)Osmotic Activity (Mechanism)Potassium Compounds (Chemical structure)
Identifiers: Product ID 65219-119_12195392-e623-4978-a1f4-33b5dbd642c3SPL ID 12195392-e623-4978-a1f4-33b5dbd642c3SPL set ID 97001218-086c-430a-9e0d-6c7031c91d94RxCUI 615107, 615111UNII 660YQ98I10, 451W47IQ8X, LX22YL083G
Pharmacologic class: Osmotic Laxative; Potassium Salt

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N465219011910 followed by a unit qualifier and the quantity

Package 65219-0119-10. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective May 6, 2024.

Indications (excerpt from the label)

INDICATIONS AND USAGE These solutions are indicated in patients requiring parenteral administration of potassium chloride with minimal carbohydrate calories and sodium chloride.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 213445

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 213445
Product	Strength	Form · route	Labeler	Product NDC
Potassium Chloride in Dextrose and Sodium Chloridedextrose monohydrate, sodium chloride, and potassium chloride	Dextrose monohydrate 50 g/1000mL + 2 more ingredients	Injection, SolutionIntravenous	Fresenius Kabi USA, LLC	65219-118

Potassium Chloride in Dextrose and Sodium Chloride NDC 65219-119